BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 30591510)

  • 1. What Causes Deep Gray Matter Atrophy in Multiple Sclerosis?
    Schoonheim MM; Geurts JJG
    AJNR Am J Neuroradiol; 2019 Jan; 40(1):107-108. PubMed ID: 30591510
    [No Abstract]   [Full Text] [Related]  

  • 2. Determinants of Deep Gray Matter Atrophy in Multiple Sclerosis: A Multimodal MRI Study.
    Pontillo G; Cocozza S; Lanzillo R; Russo C; Stasi MD; Paolella C; Vola EA; Criscuolo C; Borrelli P; Palma G; Tedeschi E; Morra VB; Elefante A; Brunetti A
    AJNR Am J Neuroradiol; 2019 Jan; 40(1):99-106. PubMed ID: 30573464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deep gray matter atrophy in neuromyelitis optica spectrum disorder and multiple sclerosis.
    Hyun JW; Park G; Kwak K; Jo HJ; Joung A; Kim JH; Lee SH; Kim S; Lee JM; Kim SH; Kim HJ
    Eur J Neurol; 2017 Feb; 24(2):437-445. PubMed ID: 28009104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling the relationship among gray matter atrophy, abnormalities in connecting white matter, and cognitive performance in early multiple sclerosis.
    Kuceyeski AF; Vargas W; Dayan M; Monohan E; Blackwell C; Raj A; Fujimoto K; Gauthier SA
    AJNR Am J Neuroradiol; 2015 Apr; 36(4):702-9. PubMed ID: 25414004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of regional brain atrophy in children with multiple sclerosis: Gray matters.
    Yeh EA; Eshaghi A
    Neurology; 2019 Apr; 92(15):694-695. PubMed ID: 30867265
    [No Abstract]   [Full Text] [Related]  

  • 6. Multi-parametric structural magnetic resonance imaging in relation to cognitive dysfunction in long-standing multiple sclerosis.
    Daams M; Steenwijk MD; Schoonheim MM; Wattjes MP; Balk LJ; Tewarie PK; Killestein J; Uitdehaag BM; Geurts JJ; Barkhof F
    Mult Scler; 2016 Apr; 22(5):608-19. PubMed ID: 26209593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association of cognitive impairment with gray matter atrophy and cortical lesion load in clinically isolated syndrome.
    Diker S; Has AC; Kurne A; Göçmen R; Oğuz KK; Karabudak R
    Mult Scler Relat Disord; 2016 Nov; 10():14-21. PubMed ID: 27919482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mapping Deep Gray Matter Iron in Multiple Sclerosis by Using Quantitative Magnetic Susceptibility.
    Barkhof F; Thomas DL
    Radiology; 2018 Nov; 289(2):497-498. PubMed ID: 30015585
    [No Abstract]   [Full Text] [Related]  

  • 9. Gray matter atrophy is associated with functional connectivity reorganization during the Paced Auditory Serial Addition Test (PASAT) execution in Multiple Sclerosis (MS).
    Baltruschat SA; Ventura-Campos N; Cruz-Gómez ÁJ; Belenguer A; Forn C
    J Neuroradiol; 2015 Jun; 42(3):141-9. PubMed ID: 25857687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gray matter trophism, cognitive impairment, and depression in patients with multiple sclerosis.
    Pravatà E; Rocca MA; Valsasina P; Riccitelli GC; Gobbi C; Comi G; Falini A; Filippi M
    Mult Scler; 2017 Dec; 23(14):1864-1874. PubMed ID: 28169581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spin echo transverse relaxation and atrophy in multiple sclerosis deep gray matter: A two-year longitudinal study.
    Uddin MN; Lebel RM; Seres P; Blevins G; Wilman AH
    Mult Scler; 2016 Aug; 22(9):1133-43. PubMed ID: 26503237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole brain and deep gray matter atrophy detection over 5 years with 3T MRI in multiple sclerosis using a variety of automated segmentation pipelines.
    Chu R; Kim G; Tauhid S; Khalid F; Healy BC; Bakshi R
    PLoS One; 2018; 13(11):e0206939. PubMed ID: 30408094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cortical atrophy patterns in multiple sclerosis are non-random and clinically relevant.
    Steenwijk MD; Geurts JJ; Daams M; Tijms BM; Wink AM; Balk LJ; Tewarie PK; Uitdehaag BM; Barkhof F; Vrenken H; Pouwels PJ
    Brain; 2016 Jan; 139(Pt 1):115-26. PubMed ID: 26637488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole brain and grey matter volume of Japanese patients with multiple sclerosis.
    Akaishi T; Nakashima I; Mugikura S; Aoki M; Fujihara K
    J Neuroimmunol; 2017 May; 306():68-75. PubMed ID: 28385190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A two-year study using cerebral gray matter volume to assess the response to fingolimod therapy in multiple sclerosis.
    Yousuf F; Dupuy SL; Tauhid S; Chu R; Kim G; Tummala S; Khalid F; Weiner HL; Chitnis T; Healy BC; Bakshi R
    J Neurol Sci; 2017 Dec; 383():221-229. PubMed ID: 29146095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gray matter atrophy in multiple sclerosis: a longitudinal study.
    Fisher E; Lee JC; Nakamura K; Rudick RA
    Ann Neurol; 2008 Sep; 64(3):255-65. PubMed ID: 18661561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting cognitive decline in multiple sclerosis: a 5-year follow-up study.
    Eijlers AJC; van Geest Q; Dekker I; Steenwijk MD; Meijer KA; Hulst HE; Barkhof F; Uitdehaag BMJ; Schoonheim MM; Geurts JJG
    Brain; 2018 Sep; 141(9):2605-2618. PubMed ID: 30169585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association Between Thoracic Spinal Cord Gray Matter Atrophy and Disability in Multiple Sclerosis.
    Schlaeger R; Papinutto N; Zhu AH; Lobach IV; Bevan CJ; Bucci M; Castellano A; Gelfand JM; Graves JS; Green AJ; Jordan KM; Keshavan A; Panara V; Stern WA; von Büdingen HC; Waubant E; Goodin DS; Cree BA; Hauser SL; Henry RG
    JAMA Neurol; 2015 Aug; 72(8):897-904. PubMed ID: 26053119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinically Isolated Syndrome Suggestive of Multiple Sclerosis: Dynamic Patterns of Gray and White Matter Changes-A 2-year MR Imaging Study.
    Rocca MA; Preziosa P; Mesaros S; Pagani E; Dackovic J; Stosic-Opincal T; Drulovic J; Filippi M
    Radiology; 2016 Mar; 278(3):841-53. PubMed ID: 26348234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sample size requirements for one-year treatment effects using deep gray matter volume from 3T MRI in progressive forms of multiple sclerosis.
    Kim G; Chu R; Yousuf F; Tauhid S; Stazzone L; Houtchens MK; Stankiewicz JM; Severson C; Kimbrough D; Quintana FJ; Chitnis T; Weiner HL; Healy BC; Bakshi R
    Int J Neurosci; 2017 Nov; 127(11):971-980. PubMed ID: 28100092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.